MENU
+Compare
CHEOF
Stock ticker: OTC
AS OF
Sep 22 closing price
Price
$202.61
Change
+$2.33 (+1.16%)
Capitalization
12.48B

CHEOF stock forecast, quote, news & analysis

Cochlear is the leading cochlear implant device manufacturer with around 60% global market share... Show more

CHEOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for CHEOF with price predictions
Sep 23, 2025

CHEOF saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for CHEOF moved out of overbought territory on September 18, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 62 similar instances where the indicator exited the overbought zone. In of the 62 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CHEOF turned negative on September 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CHEOF's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 12, 2025. You may want to consider a long position or call options on CHEOF as a result. In of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CHEOF moved above its 50-day moving average on September 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CHEOF crossed bullishly above the 50-day moving average on September 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

CHEOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 202 cases where CHEOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHEOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.299) is normal, around the industry mean (59.795). P/E Ratio (51.671) is within average values for comparable stocks, (37.619). CHEOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.703). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (8.576) is also within normal values, averaging (79.344).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

A.I.Advisor
published Dividends

CHEOF paid dividends on October 18, 2021

CochLear Ltd. CHEOF Stock Dividends
А dividend of $1.40 per share was paid with a record date of October 18, 2021, and an ex-dividend date of September 23, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.53B. The market cap for tickers in the group ranges from 1.86K to 233.03B. ABT holds the highest valuation in this group at 233.03B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 2%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 11%. MCRXF experienced the highest price growth at 100%, while USAQ experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -30%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was 102%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 76
Price Growth Rating: 60
SMR Rating: 88
Profit Risk Rating: 93
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
CHEOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
1 University Avenue
Phone
+61 294286555
Employees
4800
Web
https://www.cochlear.com